Skip to main content

Bair Teresa Brophy's Form 4 filing

Kura Oncology, Inc.KURA · filed May 20, 2024

Accession no.
0000950170-24-062585
Filed
May 20, 2024
Trade date
May 20, 2024
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 1 non-derivative transaction. Open-market sales total $57.9K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bair Teresa BrophyCIK 0001813058Officer (Chief Legal Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 20, 2024Common StockSSaleDisposed−2,615$22.15F3−$57,922.2568,979Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

This transaction was executed in multiple trades at prices ranging from $22.06 to $22.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)